The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size

被引:117
|
作者
Watt, K. I. [1 ,2 ]
Turner, B. J. [3 ]
Hagg, A. [1 ]
Zhang, X. [2 ,4 ]
Davey, J. R. [1 ]
Qian, H. [1 ]
Beyer, C. [1 ]
Winbanks, C. E. [1 ]
Harvey, K. F. [2 ,4 ,5 ]
Gregorevic, P. [1 ,6 ,7 ,8 ]
机构
[1] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia
[2] East Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia
[3] Univ Melbourne, Florey Inst Neurosci & Med Hlth, Melbourne, Vic 3010, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia
[5] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[6] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[7] Univ Melbourne, Dept Physiol, Melbourne, Vic 3010, Australia
[8] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
来源
NATURE COMMUNICATIONS | 2015年 / 6卷
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CARDIOMYOCYTE PROLIFERATION; MOLECULAR-MECHANISMS; TISSUE-GROWTH; ORGAN SIZE; TARGET; MECHANOTRANSDUCTION; REGENERATION; COACTIVATOR; YAP/TAZ; MTORC1;
D O I
10.1038/ncomms7048
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Yes-associated protein (YAP) is a core effector of the Hippo pathway, which regulates proliferation and apoptosis in organ development. YAP function has been extensively characterized in epithelial cells and tissues, but its function in adult skeletal muscle remains poorly defined. Here we show that YAP positively regulates basal skeletal muscle mass and protein synthesis. Mechanistically, we show that YAP regulates muscle mass via interaction with TEAD transcription factors. Furthermore, YAP abundance and activity in muscles is increased following injury or degeneration of motor nerves, as a process to mitigate neurogenic muscle atrophy. Our findings highlight an essential role for YAP as a positive regulator of skeletal muscle size. Further investigation of interventions that promote YAP activity in skeletal muscle might aid the development of therapeutics to combat muscle wasting and neuromuscular disorders.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size
    K. I. Watt
    B. J. Turner
    A. Hagg
    X. Zhang
    J. R. Davey
    H. Qian
    C. Beyer
    C. E. Winbanks
    K. F. Harvey
    P. Gregorevic
    Nature Communications, 6
  • [2] The Hippo pathway effector YAP is an early regulator of hepatic stellate cell activation
    Mannaerts, Inge
    Leite, Sofia B.
    Verhulst, Stefaan
    Thoen, Lien F.
    Claerhout, Sofie
    Halder, Georg
    van Grunsven, Leo A.
    HEPATOLOGY, 2014, 60 : 575A - 575A
  • [3] Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing
    Iwan Setiawan
    Ardo Sanjaya
    Ronny Lesmana
    Paul M Yen
    Hanna Goenawan
    Journal of Physiology and Biochemistry, 2021, 77 : 63 - 73
  • [4] Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing
    Setiawan, Iwan
    Sanjaya, Ardo
    Lesmana, Ronny
    Yen, Paul M.
    Goenawan, Hanna
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2021, 77 (01) : 63 - 73
  • [5] The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland
    Szymaniak, Aleksander D.
    Mi, Rongjuan
    McCarthy, Shannon E.
    Gower, Adam C.
    Reynolds, Taylor L.
    Mingueneau, Michael
    Kukuruzinska, Maria
    Varelas, Xaralabos
    ELIFE, 2017, 6
  • [6] Hippo pathway effector Yap promotes cardiac regeneration
    Xin, Mei
    Kim, Yuri
    Sutherland, Lillian B.
    Murakami, Masao
    Qi, Xiaoxia
    McAnally, John
    Porrello, Enzo R.
    Mahmoud, Ahmed I.
    Tan, Wei
    Shelton, John M.
    Richardson, James A.
    Sadek, Hesham A.
    Bassel-Duby, Rhonda
    Olson, Eric N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (34) : 13839 - 13844
  • [7] Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
    Hall, Chad A.
    Wang, Runsheng
    Miao, Jiangyong
    Oliva, Esther
    Shen, Xiaoyun
    Wheeler, Thomas
    Hilsenbeck, Susan G.
    Orsulic, Sandra
    Goode, Scott
    CANCER RESEARCH, 2010, 70 (21) : 8517 - 8525
  • [8] Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP
    Bui, Duyen Amy
    Lee, Wendy
    White, Anne E.
    Harper, J. Wade
    Schackmann, Ron C. J.
    Overholtzer, Michael
    Selfors, Laura M.
    Brugge, Joan S.
    SCIENCE SIGNALING, 2016, 9 (417)
  • [9] Mask Is Required for the Activity of the Hippo Pathway Effector Yki/YAP
    Sansores-Garcia, Leticia
    Atkins, Mardelle
    Moya, Ivan M.
    Shahmoradgoli, Maria
    Tao, Chunyao
    Mills, Gordon B.
    Halder, Georg
    CURRENT BIOLOGY, 2013, 23 (03) : 229 - 235
  • [10] Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
    Vanyai, Hannah K.
    Prin, Fabrice
    Guillermin, Oriane
    Marzook, Bishara
    Boeing, Stefan
    Howson, Alexander
    Saunders, Rebecca E.
    Snoeks, Thomas
    Howell, Michael
    Mohun, Timothy J.
    Thompson, Barry
    DEVELOPMENT, 2020, 147 (21):